Skip to main content
. 2023 Jun 12;10:1191315. doi: 10.3389/fmed.2023.1191315

Figure 1.

Figure 1

Schematic representation of the 177Lu-PLGA(RGF)-CXCR4L synthesis for combined therapy. (A) Microfluidic device (Droplet Junction Chip). (B) Synthesis of PLGA-entrapped RGF nanoparticles. (C) Functionalization of PLGA nanoparticles with CXCR4L. (D) Functionalization of PLGA(RGF)-CXCR4L nanoparticles with DOTA. (E) Radiolabeling of DOTA-PLGA(RGF)-CXCR4L with 177Lu.